|
ANKMY2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18119999839672E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49159999907056E-08 |
| Normal-vs-Stage2 |
9.719800E-02 |
| Normal-vs-Stage3 |
1.25129995254269E-09 |
| Normal-vs-Stage4 |
1.17460485782317E-11 |
| Stage1-vs-Stage2 |
1.341680E-02 |
| Stage1-vs-Stage3 |
8.774400E-02 |
| Stage1-vs-Stage4 |
6.604200E-04 |
| Stage2-vs-Stage3 |
3.953500E-04 |
| Stage2-vs-Stage4 |
3.85099999999916E-05 |
| Stage3-vs-Stage4 |
1.258820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.34720079115436E-11 |
| Normal-vs-AfricanAmerican |
4.865800E-02 |
| Normal-vs-Asian |
8.25189999997811E-07 |
| Caucasian-vs-AfricanAmerican |
2.748400E-02 |
| Caucasian-vs-Asian |
4.950200E-01 |
| AfricanAmerican-vs-Asian |
1.376760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.04350000546583E-09 |
| Normal-vs-Female |
1.81179999891867E-08 |
| Male-vs-Female |
2.944200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.29379999730995E-08 |
| Normal-vs-Age(41-60Yrs) |
7.62709999602151E-08 |
| Normal-vs-Age(61-80Yrs) |
7.83660000003294E-07 |
| Normal-vs-Age(81-100Yrs) |
9.445600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.778400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.683600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.075800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.280000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.830000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.126800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.639600E-04 |
| Classical-VS-Follicular |
7.596000E-03 |
| Classical-VS-Other |
9.411400E-01 |
| Classical-VS-Normal |
2.47679987630534E-10 |
| Tall-VS-Follicular |
9.49100000036118E-07 |
| Tall-VS-Other |
3.569800E-01 |
| Tall-VS-Normal |
1.202504762432E-11 |
| Follicular-VS-Other |
4.698800E-01 |
| Follicular-VS-Normal |
1.566260E-02 |
| Other-VS-Normal |
4.583700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.7685999999002E-07 |
| Normal-vs-N1 |
7.56728013584507E-13 |
| N0-vs-N1 |
1.61389999999706E-05 |
|
|
